Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
260M
-
Number of holders
-
709
-
Total 13F shares, excl. options
-
199M
-
Shares change
-
+1.19M
-
Total reported value, excl. options
-
$4.11B
-
Value change
-
+$29.7M
-
Put/Call ratio
-
0.59
-
Number of buys
-
276
-
Number of sells
-
-307
-
Price
-
$20.70
Significant Holders of Organon & Co. - Common Stock (OGN) as of Q2 2024
797 filings reported holding OGN - Organon & Co. - Common Stock as of Q2 2024.
Organon & Co. - Common Stock (OGN) has 709 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 199M shares
of 260M outstanding shares and own 76.36% of the company stock.
Largest 10 shareholders include BlackRock Inc. (32.6M shares), VANGUARD GROUP INC (30.2M shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (10.1M shares), STATE STREET CORP (9.01M shares), NORDEA INVESTMENT MANAGEMENT AB (7.43M shares), LSV ASSET MANAGEMENT (6.61M shares), Slate Path Capital LP (5.39M shares), MORGAN STANLEY (5.3M shares), SOUND SHORE MANAGEMENT INC /CT/ (4.87M shares), and GEODE CAPITAL MANAGEMENT, LLC (4.17M shares).
This table shows the top 709 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.